MITF and melanoma: Collectively, these findings emphasize the profound impact of miRNAs on treatment resistance in melanoma, particularly through their intricate interactions with SOX10 and MITF, and suggest that therapeutic strategies targeting these regulatory networks may hold promise for overcoming resistance and improving patient outcomes.